| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/24/2004 | WO2004052923A2 Process for the preparation of bicyclic hexa-peptide nepadutant |
| 06/24/2004 | WO2004052922A2 Peptides, antibodies thereto, and their use in the treatment of central nervous system damage |
| 06/24/2004 | WO2004052916A2 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids |
| 06/24/2004 | WO2004052915A2 Novel cyclic peptides comprising alpha-, beta- and gamma- amino acids |
| 06/24/2004 | WO2004052404A2 Glycogen synthase kinase-3 inhibitors |
| 06/24/2004 | WO2004026894A3 Synthesis and characterization of novel systems for guidance and vectorization of compounds having a therapeutic activity |
| 06/24/2004 | WO2004011650A3 Antigens encoded by alternative reading frame from pathogenic viruses |
| 06/24/2004 | WO2003092736A3 Peptide nucleic acid conjugates with transporter peptides |
| 06/24/2004 | US20040122214 Glycoprotein conjugate for the prevention lymphadenopathy associated viral infection; viricides |
| 06/24/2004 | US20040121959 Comprises cyclic amino acid sequences for use in treatment and prevention of nervous system, inflammatory, pain, asthmatic, urogenital, skin and cancer disorders |
| 06/24/2004 | US20040121958 Methods of alleviating neuropathic pain |
| 06/24/2004 | US20040121429 Comprises polypeptide with angiotensin converting enzyme activity for us in identifying modulators for treatment of cardiovascular, arthrosclerotic and hypertensive disorders |
| 06/24/2004 | US20040121412 Beta secretase exosite binding peptides and methods for identifying beta secretase modulators |
| 06/24/2004 | US20040120951 Human-type anti-blood coagulation factor viii antibody |
| 06/24/2004 | CA2509374A1 Glycogen synthase kinase-3 inhibitors |
| 06/24/2004 | CA2508847A1 Central nervous system damage |
| 06/24/2004 | CA2508696A1 Process for the preparation of bicyclic peptide compounds |
| 06/23/2004 | EP1431306A1 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 06/23/2004 | EP1430302A2 Inhibitors of glycosaminoglycans |
| 06/23/2004 | EP1430076A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 06/23/2004 | EP1430075A2 Antibacterial macrocycles |
| 06/23/2004 | EP1429796A2 Peptide antiangiogenic drugs |
| 06/23/2004 | EP1429763A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 06/23/2004 | EP1169470B1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |
| 06/23/2004 | CN1507451A Cyclosporin-pro-drug and use thereof as a medicament |
| 06/23/2004 | CN1507339A Use of 3-position cyclosporin derivatives for hair growth |
| 06/23/2004 | CN1154730C Compounds and methods for diagnosis of tuberculosis |
| 06/23/2004 | CN1154657C Cyclic peptide analogs of somatostatin |
| 06/23/2004 | CN1154656C Memory-improving peptides and their application |
| 06/22/2004 | US6753408 Peptides having antiangiogenic activity |
| 06/22/2004 | US6753313 Multimeric Apoa-I agonist compounds |
| 06/22/2004 | US6753157 Monitoring protein activity in sample; conjugate binding protein to peptide substrate, incubate with protein kinase, measure activity of kinase |
| 06/22/2004 | CA2276107C Improved substrates for human cytomegalovirus protease |
| 06/22/2004 | CA2117904C Methods and reagents for diagnosis of autoantibodies |
| 06/17/2004 | WO2004050851A2 Prion protein ligands and methods of use |
| 06/17/2004 | WO2004050690A1 NOVEL χ-CONOTOXIN PEPTIDES (-I) |
| 06/17/2004 | WO2004050689A2 Aza-peptides |
| 06/17/2004 | WO2004050688A1 NOVEL χ-CONOTOXIN PEPTIDES (-II) |
| 06/17/2004 | WO2004050687A2 Cyclosporins for the treatment of autoimmune diseases |
| 06/17/2004 | WO2004050685A2 Antifungal therapeutic agents |
| 06/17/2004 | US20040116656 Memory-enhancing peptides and the use thereof |
| 06/17/2004 | US20040116655 Viricides |
| 06/17/2004 | US20040116654 Isolated polypeptides; genetic engineering; quantitative analysis |
| 06/17/2004 | US20040116336 Peptide derivatives |
| 06/17/2004 | US20040115220 Vaccine |
| 06/17/2004 | US20040115216 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 06/17/2004 | US20040114780 Pixel arrays |
| 06/17/2004 | CA2836951A1 Prion protein ligands and methods of use |
| 06/17/2004 | CA2507936A1 Prion protein ligands and methods of use |
| 06/17/2004 | CA2505150A1 Aza-peptides |
| 06/16/2004 | EP1427820A2 Modified factor ix |
| 06/16/2004 | EP1427758A2 Compositions and methods of treating diabetes |
| 06/16/2004 | EP1427710A2 Method for the production of cna |
| 06/16/2004 | EP1427432A2 Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives |
| 06/16/2004 | EP1246839B1 Depsipeptide and congeners thereof for use as immunosuppressants |
| 06/16/2004 | EP0787299B1 Receptor for a bacillus thuringiensis toxin |
| 06/16/2004 | CN1504479A Bone formation stimulant, synthetic method and uses thereof |
| 06/16/2004 | CN1153830C Modulators of anchoring protein function |
| 06/15/2004 | US6750321 Insulin-like growth factor agonist molecules |
| 06/15/2004 | US6750200 M2GlyR derived channel forming peptides |
| 06/15/2004 | US6750199 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| 06/15/2004 | CA2109256C Technetium or rhenium-binding bi-hapten derivatives, a process for their preparation, diagnostic and therapeutic application, and kits and immunological reagents containing same |
| 06/15/2004 | CA2049921C Allergenic proteins from ragweed and uses therefor |
| 06/10/2004 | WO2004047771A2 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
| 06/10/2004 | WO2004047762A2 Methods for treating cancer using porimin as a target |
| 06/10/2004 | WO2003104266A3 PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F2alpha RECEPTOR |
| 06/10/2004 | WO2003095475A8 Peptide compounds and their use as protease substrates |
| 06/10/2004 | US20040110695 Phospholipid vesicle having exogenous antigen orpolynucleic acid coding for antigen; adapted to be phagocytosed by antigen presenting cells |
| 06/10/2004 | US20040110690 Transporter peptide capable of translocating across biological membrane of pancreatic B-cells, hepatocytes, colon cells, muscle cells and/or lung cells; drug delivery; biochemical conjugation |
| 06/10/2004 | US20040110687 Administering immunomodulatory peptides for side effect reduction from cancer chemotherapy or radiotherapy; diarrhea, mucositis, stomatitis and proctitis |
| 06/10/2004 | US20040110678 Novel drug delivery system |
| 06/10/2004 | US20040110666 Cyclosporins for treatment of autoimmune disorders and diseases |
| 06/10/2004 | US20040110228 Combinatorial organic synthesis of unique biologically active compounds |
| 06/10/2004 | CA2507215A1 Methods for treating cancer using porimin as a target |
| 06/10/2004 | CA2507045A1 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
| 06/09/2004 | EP1426062A2 Radiolabeled annexins |
| 06/09/2004 | EP1425575A1 A novel cancer marker and uses therefor in the diagnosis of cancer |
| 06/09/2004 | EP1425391A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes |
| 06/09/2004 | EP1425301A2 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals |
| 06/09/2004 | EP1425296A1 Organic compounds with biological activity as thrombin inhibitors and use thereof |
| 06/09/2004 | EP1425029A1 Peptidomimetics of biologically active metallopeptides |
| 06/09/2004 | EP1036089B1 Wound healing compositions |
| 06/09/2004 | CN1502631A Carcino-embryonic untigen specific combined peptide and fusion protein with TNF-alpha |
| 06/09/2004 | CN1502625A Oligopeptide suppressor of matrix metalloprotease 2 |
| 06/08/2004 | US6747143 Methods for polymer synthesis |
| 06/08/2004 | US6747135 Fluorescent dye binding peptides |
| 06/08/2004 | US6747125 Gonadotropic release hormone (gnrh ) antagonists prevents ovulation of female mammalian eggs and/or the release of steroids by the gonads; used to treat steroid-dependent tumors; agonists can be used for control of reproduction |
| 06/08/2004 | US6747007 Cationic, polyphemusin-like peptides |
| 06/08/2004 | CA2225597C Use of a organopolysiloxane as a perfume fixative and/or for prolonging its release |
| 06/03/2004 | WO2004046166A2 Modified alpha-msh peptides and derivatives thereof |
| 06/03/2004 | WO2004018519A3 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 06/03/2004 | WO2004009021A3 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/03/2004 | WO2003100432A3 Method for identifying immunoreactive peptides |
| 06/03/2004 | WO2003096022A8 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 06/03/2004 | US20040106636 said analgesic contains an opioid moiety of chemically modified morphine that binds to and activates an mu opioid receptor (MOR), and a tachykinin peptide substance P (SP) peptide fragment moiety that binds to and activates an SPR |
| 06/03/2004 | US20040106557 Peptide ligands for prostate specific antigen |
| 06/03/2004 | US20040106552 amyloid precursor proteins; for use in treatment of Alzheimer's disease/neurodegenerative diseases and as cognitive enhancers |
| 06/03/2004 | US20040106545 Compounds and methods for modulating cell adhesion |
| 06/03/2004 | US20040105857 Methods and compositions for enhancing angiogenesis |